Buscar resultados de ensayos clínicos
Hereditary Angioedema - 12 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks Condición: Hereditary Angioedema Fecha: 2006-02-07 Intervenciones:
|
| Completed |
Nombre del estudio: A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor Condición: Hereditary Angioedema Types I and II Fecha: 2012-12-24 Intervenciones:
|
| Completed |
Nombre del estudio: A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route Condición: Hereditary Angioedema Types I and II Fecha: 2012-04-10 Intervenciones:
|
| Completed |
Nombre del estudio: Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert Condición: Hereditary Angioedema Types I and II Fecha: 2011-11-07 Intervenciones: Biological: Berinert, lyophilizate for IV application containing 500 IU C1-INH to be reconstituted with 10 mL water for injection |
| Completed |
Nombre del estudio: Kinetics, Efficacy and Safety of C1-Esteraseremmer-N Condición:
Fecha: 2005-07-04 Intervenciones: Drug: C1 inhibitor concentrate |
| Completed |
Nombre del estudio: CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema Condición: Hereditary Angioedema (HAE) Fecha: 2025-11-04 Intervenciones: Fully human immunoglobulin G subclass 4/lambda recombinant inhibitor monoclonal antibody administered subcutaneously (SC) |
| Completed |
Nombre del estudio: A Study of STAR-0215 in Participants With Hereditary Angioedema Condición: Hereditary Angioedema Fecha: 2025-11-04 Intervenciones: STAR-0215 will be administered as a subcutaneous bolus injection. |
| COMPLETED |
Nombre del estudio: A Study in Adults With Hereditary Angioedema (HAE) Who Currently Receive Icatibant at Home Condición: Hereditary Angioedema (HAE) Fecha: 2025-11-04 Intervenciones: No Intervention will be administered in this study. |
| COMPLETED |
Nombre del estudio: A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II Condición: Hereditary Angioedema (HAE) Fecha: 2025-11-04 |
| COMPLETED |
Nombre del estudio: A Study of STAR-0215 in Participants With Hereditary Angioedema Condición: Hereditary Angioedema Fecha: 2025-11-04 Intervenciones: STAR-0215 will be administered as a subcutaneous bolus injection. |